Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Soil Ecosystem02:23

The Soil Ecosystem

25.0K
Plants obtain inorganic minerals and water from the soil, which acts as a natural medium for land plants. The composition and quality of soil depend not only on the chemical constituents but also on the presence of living organisms. In general, soils contain three major components:
25.0K
What is an Ecosystem?01:17

What is an Ecosystem?

47.3K
Overview
47.3K
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

857
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
857
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

213
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
213
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

248
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
248
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

370
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
370

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment.

NPJ biofilms and microbiomes·2023
Same author

First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial).

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Quantitative proteomic profiling of shake flask versus bioreactor growth reveals distinct responses of <i>Agrobacterium tumefaciens</i> for preparation in molecular pharming.

Canadian journal of microbiology·2020
Same author

Corrigendum to "Effects of therapeutic hypothermia on the gut microbiota and metabolome of infants suffering hypoxic-ischemic encephalopathy at birth" [Int. J. Biochem. Cell Biol. 93 (December) (2017), 110-118].

The international journal of biochemistry & cell biology·2019
Same author

Development of the faecal microbiota in foals.

Equine veterinary journal·2015
Same author

Stability and biological activity of wild blueberry (Vaccinium angustifolium) polyphenols during simulated in vitro gastrointestinal digestion.

Food chemistry·2014

Related Experiment Video

Updated: Feb 10, 2026

In Situ Chemotaxis Assay to Examine Microbial Behavior in Aquatic Ecosystems
07:23

In Situ Chemotaxis Assay to Examine Microbial Behavior in Aquatic Ecosystems

Published on: May 5, 2020

7.8K

Using bugs as drugs: Microbial ecosystem therapeutics.

E Allen-Vercoe1, E O Petrof2

  • 1Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON.

Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|May 18, 2018
PubMed
Summary
This summary is machine-generated.

Restoring gut microbiota diversity is key for health. Microbial ecosystem therapeutics (MET) offer a safer alternative to fecal microbial therapy (FMT) for treating diseases caused by microbiota imbalance.

More Related Videos

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.9K
Fluorescently Labeled Bacteria as a Tracer to Reveal Novel Pathways of Organic Carbon Flow in Aquatic Ecosystems
09:35

Fluorescently Labeled Bacteria as a Tracer to Reveal Novel Pathways of Organic Carbon Flow in Aquatic Ecosystems

Published on: September 13, 2019

7.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

In Situ Chemotaxis Assay to Examine Microbial Behavior in Aquatic Ecosystems
07:23

In Situ Chemotaxis Assay to Examine Microbial Behavior in Aquatic Ecosystems

Published on: May 5, 2020

7.8K
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.9K
Fluorescently Labeled Bacteria as a Tracer to Reveal Novel Pathways of Organic Carbon Flow in Aquatic Ecosystems
09:35

Fluorescently Labeled Bacteria as a Tracer to Reveal Novel Pathways of Organic Carbon Flow in Aquatic Ecosystems

Published on: September 13, 2019

7.5K

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • The human gut microbiota is crucial for maintaining health.
  • Modern lifestyles, including antibiotic overuse, disrupt microbiota diversity, increasing disease susceptibility (e.g., *Clostridium difficile* infection).
  • Restoring gut microbial diversity is a therapeutic goal.

Purpose of the Study:

  • To introduce microbial ecosystem therapeutics (MET) as an alternative to fecal microbial therapy (FMT).
  • To highlight MET's potential to address risks and challenges associated with FMT.
  • To advocate for the use of defined microbial communities as therapeutic agents ('bugs as drugs').

Main Methods:

  • Review of current literature on gut microbiota, FMT, and MET.
  • Comparison of FMT and MET approaches regarding safety, efficacy, and implementation.
  • Discussion of the potential of selected microbial communities in restoring gut balance.

Main Results:

  • Fecal microbial therapy (FMT) shows promise but has risks and implementation barriers.
  • Microbial ecosystem therapeutics (MET) utilize selected, defined microbial communities.
  • MET offers a potential solution to mitigate FMT risks and restore microbiota function.

Conclusions:

  • Microbial ecosystem therapeutics (MET) represent a promising advancement in microbiota restoration.
  • MET may overcome limitations associated with traditional fecal microbial therapy (FMT).
  • The concept of 'bugs as drugs' signifies a paradigm shift in treating microbiota-associated diseases.